From August 17, 2022, China's National Medical Products Administration (NMPA) is seeking public comments on draft the Supervision and Administration of Cosmetics and the Measures for the Supervision and Administration of the Production and Operation of Cosmetics. The measures will be enforced to keep in check and control over possible occurrences of irregularities such as the manufacture and sale of counterfeit or substandard products, and the illegal or exaggerated publicity of product efficacy. Public comments can be submitted till September 06, 2022.